![]()
|
|
||||||||
J Biol Chem, Vol. 275, Issue 2, 1112-1118, January 14, 2000
From the Section of Infectious Diseases, Department of Internal Medicine, Yale University School of Medicine, New Haven, Connecticut 06520-8022
| |
ABSTRACT |
|---|
|
|
|---|
We sought to identify and characterize
peroxisomes in the apicomplexan parasite Toxoplasma gondii.
To initiate this process, we first cloned and sequenced the gene for
T. gondii catalase (EC 1.11.1.6), a marker enzyme for
peroxisomes in eukaryotic cells. The gene predicts a protein of 57.2 kDa and 502 amino acids and has a strong homology to other eukaryotic
catalases. A polyclonal antiserum raised against a glutathione
S-transferase fusion protein recognized a single band with
a molecular mass of 63 kDa by immunoblot. By immunofluorescence
T. gondii catalase is present primarily in a punctate
staining pattern anterior to the parasite nucleus. This compartment is
distinguishable from other parasite organelles, namely micronemes,
rhoptries, dense granules, and the apicoplast. Cytochemical
visualization of catalase using diaminobenzidine precipitation gives a
vesicular staining pattern anterior to the nucleus at the light level
and round, vesicular structures with an estimated diameter of 100-300
nm by electron microscopy. T. gondii catalase has a
putative C-terminal peroxisomal targeting signal in the last 3 amino
acids (-AKM). Expression of T. gondii catalase in mammalian
cells results in peroxisomal localization, whereas a construct lacking
the targeting signal remains in the cytosol. Furthermore, addition of
-AKM to the C terminus of chloramphenicol acetyltransferase is
sufficient to target this protein to peroxisomes. These results provide
the first evidence for peroxisomes in Apicomplexan parasites.
Apicomplexan parasites such as Toxoplasma,
Cryptosporidium, Plasmodium, and
Eimeria are prevalent worldwide and cause disease in humans
and livestock. Toxoplasma gondii is responsible for opportunistic infections in immunosuppressed individuals, in particular AIDS and transplant patients, and congenital infections in newborns.
T. gondii is an obligate intracellular parasite that can
survive and replicate inside many cell types, including activated macrophages. This suggests that the parasite has mechanisms to evade
the macrophage respiratory burst (1). Previous studies have shown that
the parasite is remarkably resistant to hydrogen peroxide and can
quench released oxygen radicals (2). These phenomena are attributed to
the high level expression of catalase and superoxide dismutase (3) and
their ability to decompose H2O2. Despite their
importance, no further effort has been made to characterize these
enzymes in detail.
Catalase (EC 1.11.1.6) is a marker enzyme of peroxisomes or
microbodies. These subcellular organelles compartmentalize more than 50 different enzymes that intersect with a large variety of anabolic and
metabolic pathways. In mammalian cells, these pathways include peroxide
metabolism, A well characterized example of microbodies in protozoan parasites are
the glycosomes of the Kinetoplastidae, e.g.
Leishmania and Trypanosoma (6). These organelles,
most prominent in the bloodstream form of these parasites, notably
compartmentalize glycolytic enzymes but surprisingly do not contain
catalase. Protein import into glycosomes is thought to be mediated by a
similar mechanism as reported for mammalian peroxisomal import. In the phylum Apicomplexa, however, peroxisomes or related particles have
never been defined.
In this study we report the cloning of T. gondii catalase,
its subcellular localization in peroxisomes, and its targeting, mediated through a PTS1 signal. This is the first evidence for the
existence of a peroxisomal compartment in any Apicomplexan parasite.
Cell Culture and Growth of T. gondii--
The RH strain of
T. gondii was maintained by growth in monolayers of either
African Green monkey (Vero) cells or human foreskin fibroblasts as
described previously (7). Chinese hamster ovary (CHO) cells were
cultured in Cloning and Sequencing of T. gondii Catalase--
A catalase
proximal heme-ligand signature (PROSITE, Swiss Institute of
Bioinformatics) was found in two sequences of the EST data base of the
Toxoplasma EST project (8). Both lambda phage clones
(GenBankTM accession numbers W9973 and W6349) were obtained
from Genome Systems (St. Louis, MO), in vivo excised with
VCSM13 (Stratagene, Menasha, WI) as helper phage and sequenced. The
upstream sequence was obtained by 5'-rapid amplification of cDNA
ends (anchor primers: R1, R2, and R3 see Table
I) and by RT-PCR with a degenerate primer (Fdeg) against a highly conserved motif in eukaryotic catalases and two
specific reverse primers (R4 and R5). A second 5'- rapid amplification
of cDNA ends (anchor primers: R6, R7, and R9) revealed the missing
upstream region. The sequence was confirmed by RT-PCR with specific
primers against the 5'- and 3'-untranslated regions (F4 and R0), and
four independent clones were sequenced. For RT-PCR and rapid
amplification of cDNA ends applications, RNA was isolated using
TRIzol reagent and transcribed with Superscript II reverse transcriptase according to the manufacturer's instructions (Life Technologies, Inc.). DNA sequences were obtained by dideoxy sequencing of both strands at the W. M. Keck Sequencing Center, Yale
University School of Medicine. The strategy for determining the
nucleotide sequence of T. gondii catalase is shown in Fig.
1.
Production of Antiserum to a GST-Catalase Fusion--
The
nucleotide sequence that codes for the C-terminal part of T. gondii catalase (aa 335-502) was amplified by PCR (primers ExF
and ExR) and cloned in frame into the BamHI and
XmaI site of the pGEX-4T-1 expression vector (Amersham
Pharmacia Biotech). The resulting glutathione S-transferase
(GST) fusion protein was expressed in the Escherichia coli
strain DH5 Immunoblot with Anti-T. gondii Catalase--
About 5 × 106 parasites (or an equivalent amount of host cell
material) were collected by centrifugation, separated on a 10% SDS-polyacrylamide gel, and transferred onto nitrocellulose membrane. The membranes were probed with a 1:500 dilution of anti-T.
gondii catalase antiserum, followed by a 1:2000 dilution of
horseradish peroxidase-conjugated anti-rabbit IgG antibody
(Calbiochem). The signal was visualized with the ECL kit (Amersham
Pharmacia Biotech). As a control, incubation with preimmune serum at a
1:100 dilution was performed.
Antibody Purification--
The rabbit antiserum to T. gondii catalase was purified by adsorption to the 47-kDa band of
the purified recombinant antigen on an immunoblot, as described
previously (10). Alternatively, the antiserum was affinity purified
against the GST fusion protein coupled to cyanogen bromide-activated
agarose (Sigma). The antibody was bound to the column in
phosphate-buffered saline (PBS), pH 7.4, eluted with 0.2 M
glycine, pH 2.8, and the pH of the eluate was immediately readjusted by
adding 1 M Tris base.
Immunofluorescence Assay--
The immunofluorescence assay (IFA)
for intracellular parasites was performed as described previously (11),
using 3% paraformaldehyde as fixative. Extracellular parasites were
fixed in ice-cold acetone for 15 min and then processed similarly.
Controls included incubation with preimmune serum, secondary antibody
alone, and competition experiments with the purified GST fusion
protein. The following dilutions of antibodies were used: fluorescein
isothiocyanate (FITC)-linked goat anti-rabbit IgG (Calbiochem) at
1:500; rhodamine-linked goat anti-mouse (Roche Molecular Biochemicals)
at 1:500; affinity purified rabbit anti-catalase at 1:5; murine
monoclonal anti-ROP2,3,4 (T3 4A7) at 1:250; murine monoclonal anti-GRA3
(T6 2H11) at 1:250; and murine monoclonal anti-MIC2 (D2R3) at 1:250.
All monoclonal antibodies were generously provided by J. F. Dubremetz, Lille, France. The apicoplast was stained with
4',6-diamidino-2-phenylindole (12).
For IFA on CHO cells, the same protocol as for intracellular parasites
was applied. Antibody concentrations used were as follows: rabbit
anti-chloramphenicol acetyltransferase antibody (5 Prime Cytochemical EM--
Diaminobenzidine (DAB) staining for
catalase was performed according to established procedures (13). In
brief, parasites were fixed for 15 min with 1.5% glutaraldehyde in 0.1 M PIPES buffer, pH 7.4, washed once in PBS, pH 7.4, and one
time in Teorell-Stenhagen buffer (T/S: 50 mM boric acid, 10 mM phosphoric acid, 2.5 mM citric acid brought
to pH 10.5 by NaOH). Following a 1-h preincubation in DAB (2 mM in T/S) at room temperature,
H2O2 was added to a final concentration of
0.15% for 1-3 h. After washing in T/S and 100 mM sodium
cacodylate buffer, pH 7.4, the sample was fixed overnight with 2.5%
glutaraldehyde in 100 mM sodium cacodylate at 4 °C and
embedded in Epon (Electron Microscopy Sciences, Fort Washington, PA).
Ultrathin 60-80 nm sections were mounted on Formvar-coated nickel
grids (Electron Microscopy Sciences). The sections were not
counterstained in order to facilitate recognition of the DAB precipitate. As a control, DAB incubations were done in the presence of
20 mM 3-amino-1,2,4-triazole or alternatively
H2O2 was omitted. For light microscopy, the
above procedure was performed on coverslips that were mounted and
examined after the H2O2 incubation.
Import Assays in Mammalian Cells--
Chloramphenicol
acetyltransferase (CAT) and T. gondii catalase expression in
CHO cells was driven by the cytomegalovirus promoter. CAT-AKM was
ligated into the HindIII and KpnI site (CATFHind, CATAKMKpn) of pcDNA3.1/Zeo(+) (Invitrogen, Carlsbad, CA). For a
cytosolic control, CAT in the pcDNA3.1/Zeo/CAT vector (Invitrogen) was used. T. gondii catalase was cloned into NheI
and BamHI sites of pcDNA3.1/Zeo(+) using NheCat, AKMBgl
(full-length catalase), and CYPBgl (C-terminal truncation) as primers.
CHO cells were transfected using SuperFect (Qiagen, Valencia, CA),
following the manufacturer's instructions. The cells were plated on
coverslips 24-48 h after transfection, and IFA was performed 24 h later.
Analysis of the Catalase Sequence--
The deduced amino acid
sequence of T. gondii catalase encodes a protein of 502 residues with a predicted molecular mass of 57.2 kDa (Fig.
2). Evaluation of the protein sequence by
BLASTP (14) shows a high degree of identity with other catalases
(e.g. 53% identity with human catalase), whereas comparison
of the T. gondii catalase nucleotide sequence with
eukaryotic catalases reveals only minimal similarity. This suggests,
along with additional data provided below (Fig. 4), that the deduced
catalase sequence is derived from T. gondii and not from
host cell contamination.
Further analysis confirms that this protein is indeed a catalase.
Foremost, both catalase consensus patterns (15) are present: the active
site signature at position 53-69 (consensus,
(IF)X(RH)X4(EQ)RX2HX2(GAS)-(GASTF)-(GAST)) and at position 343-351 the proximal heme ligand signature (consensus, R-(LIVMFSTAN)-F-(GASTNP)YXD(AST)-(QEH)) (Fig.
3).
Residues that comprise the active site are absolutely identical to
human catalase (Phe-142, Phe-150, and Phe-53 as distal and His-207 and
Arg-343 as proximal heme binding partners; Arg-61, Arg-101, and Arg-354
as binding partners for the propionate groups of the heme). Residues
neighboring the active center are also conserved (Tyr-347, Asp-54,
His-64, Val-135, and Phe-323), with minor alterations (S346A and L50M)
in human catalase (16). Residues that are thought to play a role in the
catalytic mechanism are also conserved (His-64, Asn-137, Ser-103, and
Tyr-347) (17).
Some catalases, e.g. human or bovine catalase, are
NADPH-containing enzymes (16). NADPH is thought to prevent the
formation of compound II, an inactive state in the catalytic cycle
(18). Sequence conservation suggests that T. gondii catalase
may also bind NADPH as a cofactor. Residues possibly involved in NADPH binding (Arg-192, Thr-190, Asn-202, His-294, His-183, Gln-435, Trp-292,
His-224, and Val-443) and residues in the environment of the putative
NADPH-binding site (Glu-448, Phe-187, Thr-139, Pro-140, Tyr-204,
Lys-226, Gln-271, Pro-293, Val-291, Phe-439, and Leu-444) are identical
to the human sequence with the exception of Thr-190 and Glu-448
(16).
The substrate H2O2 is thought to diffuse to the
active site through an approximately 30-Å long channel (16). Residues
that build the walls of the narrow part of this channel are identical to the human sequence (Val-105, Ala-106, Asp-117, Pro-118, Phe-142, Phe-143, Phe-150, Phe-153, Ile-154, Val-185, Leu-188, Gln-157, and
Lys-158), suggesting that the range of potential substrates is similar
(19).
Most catalases exist as homotetramers. Residues that are known to be
involved in subunit interactions in Proteus mirabilis catalase are identical with the corresponding residues in T. gondii catalase (Leu-50, Asp-54, Phe-53, Asp-349, Arg-55, P. mirabilis alignment not shown) (16). Human and bovine catalases,
which have a longer C terminus, also stabilize the subunit interactions with these additional amino acids.
T. gondii catalase contains a putative peroxisomal targeting
signal (PTS1) at the C terminus. The last three residues of the protein
(-AKM) match the consensus motif of C-terminal peroxisomal targeting
signals ((S/T/A/G/C/N)-(R/K/H)-(L/I/V/M/A/F/Y)). This motif has been
shown to be a PTS1, albeit a weak one, when linked to CAT and expressed
in monkey kidney (CV1) cells (20).
Anti-catalase Antiserum Recognizes a 63-kDa Protein--
Antiserum
was raised to a fusion protein between GST and residues 335-502 of
T. gondii catalase. This region of T. gondii catalase is comparatively divergent to human catalase and was therefore
chosen as antigen.
As expected the antiserum recognizes the recombinant GST-catalase
fusion protein migrating at 47 kDa (Fig.
4, 3rd lane). This antiserum recognizes a single band on immunoblot, when tested against
whole parasites (Fig. 4, 1st lane). This protein
migrates at 63 kDa, which is in reasonable agreement with the predicted size (57.2 kDa) of T. gondii catalase. The parasite protein
expressed in CHO cells also migrates with the same
Mr (data not shown). No signal is observed with
uninfected host cells (Fig. 4, 2nd lane) or with
preimmune serum (data not shown), indicating that the band constitutes
a T. gondii protein.
Catalase Localizes to a New, Distinct Compartment Anterior to the
Nucleus by IFA--
Anti-catalase antiserum recognizes a punctate,
beaded structure anterior to the nucleus by immunofluorescence (Fig.
5). Additionally there is a weak but
specific, diffuse signal throughout the parasite, which might
correspond to a cytosolic pool of the protein. Colocalization experiments show that the catalase localization is distinct from other
parasite organelles, namely micronemes, rhoptries, dense granules, and
the apicoplast (Fig. 6).
Catalase Localization by Histocytochemistry--
Catalase was
localized in T. gondii by histocytochemistry. Catalase can
be visualized by precipitation of diaminobenzidine (DAB) under
conditions of mild fixation, high substrate (hydrogen peroxide)
concentrations, and high pH buffer. The precipitate can be seen in
light microscopy as dark spots inside the parasite (Fig.
7c). Treatment with 20 mM 3-amino-1,2,4-triazole, a catalase inhibitor, abolishes
the staining (data not shown).
By electron microscopy a specific reaction product appears in a
juxtanuclear position as a round structure of about 100-300 nm (Fig.
7, a and b). It frequently possesses a core with
a crystalloid shape. Reaction product in the mitochondrion is not
specific for catalase, since it is still prevalent under inhibitor
treatment or when the substrate hydrogen peroxide is omitted (data not shown).
Putative PTS1 Is Necessary and Sufficient for Targeting to
Mammalian Peroxisomes--
The functionality of the C-terminal -AKM
motif as a peroxisomal targeting signal was tested by expressing
T. gondii catalase in CHO cells, which provide a well
defined peroxisomal compartment. Transiently expressed full-length
T. gondii catalase localizes to particulate structures that
show the same staining pattern as peroxisomes (Fig.
8, c and e). The
truncated version of catalase, without the last three amino acids,
yields a diffuse staining pattern (Fig. 8d), which is
consistent with a predicted cytosolic localization.
To address the question whether the -AKM motif is sufficient to target
proteins to peroxisomes, CAT was used as a marker protein. CAT resides
in the cytosol and therefore has a diffuse staining pattern (Fig.
8b). Addition of -AKM to the C terminus (CAT-AKM) relocates
the protein to particulate structures (Fig. 8a), suggesting a peroxisomal localization. To confirm targeting of CAT to peroxisomes we expressed CAT-SKL, which is known to reside in peroxisomes (data not shown).
Catalase is the characteristic marker enzyme of peroxisomes and is
highly conserved across species. The deduced amino acid sequence of
T. gondii catalase has typical features of eukaryotic catalases, e.g. residues that are known to be involved in
heme binding, NADPH binding, tetramerization, and protein import are strongly conserved. This suggests a similar catalytic mechanism and
localization in peroxisomes.
We addressed the latter by analyzing catalase distribution by the
electron and light microscope. We identified a distinctive, vesicular
compartment anterior to the nucleus that does not overlap with known
organelles of the parasite. Since peroxisomal proteins reach their
subcellular destination through a specific import mechanism that is
mediated by evolutionarily conserved signals, we investigated the
functionality of the PTS1-type import signal (-AKM) of T. gondii catalase. This PTS1 motif is necessary and sufficient to
target T. gondii catalase and chloramphenicol
acetyltransferase to mammalian peroxisomes. Although we have not
identified a peroxisomal membrane, due to the difficulties in detection
of DAB precipitate in counterstained sections, our data remain
consistent with the presence of peroxisomes in T. gondii.
The enzymatic activity of catalase, the decomposition of
H2O2, and therefore the protection from
endogenously produced oxygen radicals are well established. One can
also speculate about protection from exogenous
H2O2, a mechanism that could potentially
facilitate parasite survival during infection. However, in this case, a
compartmentalization of catalase seems to be unfavorable, since
H2O2 would have to diffuse through the parasite
cytosol toward the enzyme. On the other hand, the observed pool of
catalase in the parasite cytosol could be sufficient to clear exogenous
hydrogen peroxide, whereas the peroxisomal pool might be needed to
scavenge the H2O2 production of peroxisomal enzymes.
The biochemical role of peroxisomes in T. gondii has yet to
be elucidated. Of particular interest will be to determine the contribution of peroxisomal enzymes in lipid synthesis or metabolism. The parasite seems to be deficient in its ability to synthesize cholesterol and selected phospholipids de
novo2 and presumably
acquires these components from the host cell. On the other hand,
enzymes involved in fatty acid biosynthesis are imported into the
T. gondii apicoplast, a chloroplast remnant present in many
if not all Apicomplexan parasites (21, 22). Given the presence in
T. gondii of genes for isocitrate lyase and malate synthase,
two members of the glyoxylate cycle found in plant glyoxysomes, a role
for T. gondii peroxisomes in fatty acid conversion in
succinate and ultimately to glucose is also possible.3 Determining the
relative contribution of these three pathways to lipid homeostasis
within T. gondii will require a detailed understanding of
the biochemical composition of the T. gondii peroxisomes and
may ultimately provide insights into novel therapeutic approaches.
![]()
INTRODUCTION
TOP
ABSTRACT
INTRODUCTION
MATERIALS AND METHODS
RESULTS
DISCUSSION
REFERENCES
-oxidation of fatty acids, and ether phospholipid
synthesis. Most peroxisomal enzymes are synthesized on free ribosomes
and then post-translationally imported into peroxisomes through an
evolutionarily conserved machinery (4). Several types of peroxisomal
targeting signals (PTS)1 have
been identified. PTS1, the C-terminal peroxisomal targeting signal,
resides in the last 3 amino acids that share the following consensus
motif: (S/T/A/G/C/N)-(R/K/H)-(L/I/V/M/A/F/Y) (PROSITE, Swiss Institute
of Bioinformatics). However, not all combinations have been tested, and
residues upstream of this signal are known to influence the recognition
of this motif (5).
![]()
MATERIALS AND METHODS
TOP
ABSTRACT
INTRODUCTION
MATERIALS AND METHODS
RESULTS
DISCUSSION
REFERENCES
-minimum Eagle's medium supplemented with 3.5% fetal
bovine serum, 2 mM L-glutamine, and
penicillin/streptomycin at 37 °C in 5% CO2 atmosphere.
Primer sequences

View larger version (5K):
[in a new window]
Fig. 1.
Sequencing strategy. Catalase of
T. gondii was cloned by a combination of techniques. The
bars show the method used to determine the indicated part of
the sequence. The 5'- and 3'-untranslated regions are shown by
open boxes; the coding sequence is shown by the black
box. The arrows denote the positions of the
primers.
. Synthesis of the GST fusion protein was induced with 0.5 mM isopropyl-1-thio-
-D-galactopyranoside for
4-6 h at 37 °C. The protein was solubilized with
N-laurylsarcosine (9) and affinity purified on
glutathione-Sepharose beads (Sigma). Rabbit preimmune sera were
screened by immunoblot for low background recognition of T. gondii antigens, and a suitable animal was chosen. Immunization
and antiserum production were carried out by Cocalico Biologicals
(Reamstown, PA).
3 Prime
Inc., Boulder, CO) at 1:500; rabbit anti-catalase antiserum at
1:250,and rabbit anti-SKL antibody (Zymed Laboratories
Inc., South San Francisco, CA) at 1:500.
![]()
RESULTS
TOP
ABSTRACT
INTRODUCTION
MATERIALS AND METHODS
RESULTS
DISCUSSION
REFERENCES

View larger version (48K):
[in a new window]
Fig. 2.
Nucleotide sequence and predicted translation
of T. gondii catalase. The T. gondii
catalase sequence is available in GenBankTM (accession
number AF136344). The underlined bases denote the position
of the respective oligonucleotides in Table I.

View larger version (50K):
[in a new window]
Fig. 3.
Sequence alignment for catalases of various
species. Catalases from the following species are aligned with
T. gondii catalase (NCBI accession number AF136344):
H. sapiens (NCBI accession number 179950), C. elegans (NCBI accession number 1078837), S. cerevisiae
(NCBI accession number 115709). Dots in the sequence
indicate that the residues are identical to the aligned T. gondii residues, whereas a dash denotes a gap. Symbols
below the alignment show residues that have the following
possible function: distal heme binding residues are denoted by >,
proximal heme binding residues by <; residues that bind the propionate
side chains of the heme by
.
indicates residues neighboring the
active center;
indicates NADPH binding participants;
denotes
residues proposed to be involved in the catalytic mechanism;
shows
residues in the environment of NADPH;
indicates residues that build
the substrate channel;
denotes residues that are critical for
tetramerization. The putative PTS1 signals are printed in
bold, whereas the active site signature (aa 53-69) and the
proximal heme-binding signature (aa 343-351) are
underlined. The alignment was performed by
ClustalW1.73.

View larger version (9K):
[in a new window]
Fig. 4.
Immunoblot with antiserum against a
GST-catalase fusion. Whole parasite lysates (from organisms grown
in Vero cells) were probed by immunoblot with the antiserum to T. gondii catalase. A 63-kDa protein was detected in the parasite
lysate (1st lane). No signal was observed in the
negative control with lysates of uninfected Vero cells (2nd
lane). The purified GST-catalase fusion protein serves as a
positive control, migrating at the predicted size of 47 kDa
(3rd lane).

View larger version (104K):
[in a new window]
Fig. 5.
Immunofluorescence assay with anti-catalase
antibody. Affinity purified antibody to T. gondii
catalase was used for IFA with intracellular and extracellular
parasites. Intracellularly replicating parasites (a) form a
rosette inside a vacuole with the anterior end of the parasite pointing
outwards. b, such a vacuole with eight parasites is depicted
schematically on top of the phase image. In one parasite the nucleus
(N) and catalase-containing vesicles are indicated. In
extracellular parasites (c) the catalase-containing vesicles
seem to be more condensed, possibly a result of the different fixation.
d, shows the corresponding phase image to c.
Scale bar, 2 µm.

View larger version (57K):
[in a new window]
Fig. 6.
IFA colocalization of catalase with various
parasite markers. Catalase (green channel) does not
colocalize with various parasite organelles by IFA. Micronemes
(a), rhoptries (c), and dense granules
(e) (all in the red channel) are labeled with
monoclonal mouse antibodies to organellar proteins. The corresponding
phase images are shown in b and d. The
localization of the apicoplast DNA (f) is visualized by
4'6-diamidino-2-phenylindole staining (red channel) and
denoted by arrows; the arrowheads point to the
parasite nuclei. Scale bar, 2 µm.

View larger version (161K):
[in a new window]
Fig. 7.
Catalase cytochemistry by DAB
precipitation. Electron micrographs (a and
b) of intracellular parasites. M, mitochondrion;
N, nucleus; and P, peroxisome (scale
bar, 0.5 µm). The inset in a shows a
higher magnification of a labeled peroxisome (scale bar, 50 nm). In light microscopy the precipitate can be seen as dark
spots in the phase image (c, arrows). d, is
the corresponding Nomarski image for c (scale
bar, 5 µm).

View larger version (69K):
[in a new window]
Fig. 8.
Import of T. gondii catalase
and CAT in CHO cells. Peroxisomal localization of CAT-AKM
(a) and diffuse, cytosolic staining pattern (b)
of CAT lacking the PTS1 signal. Full-length T. gondii
catalase, visualized with anti-catalase antiserum, gives a particulate
staining pattern (c). Deletion of the last three amino acids
(-AKM) abolishes peroxisomal localization and gives a cytosolic
distribution (d). Typical peroxisomal staining with a
polyclonal rabbit Anti-SKL antibody is shown in e.
Scale bar, 5 µm.
![]()
DISCUSSION
TOP
ABSTRACT
INTRODUCTION
MATERIALS AND METHODS
RESULTS
DISCUSSION
REFERENCES
| |
ACKNOWLEDGEMENTS |
|---|
We thank P. Lazarow and E. Purdue for helpful discussion and reagents; E. Ullu, A. Sinai, and I. Coppens for careful reading of the manuscript; and members of the Joiner laboratory for their support.
| |
FOOTNOTES |
|---|
* This work was supported by National Institutes of Health Grant A130060 and a Burroughs Wellcome Scholar award in Molecular Parasitology (to K. A. J.).The costs of publication of this article were defrayed in part by the payment of page charges. The article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.
The nucleotide sequence(s) reported in this paper has been submitted to the GenBankTM/EMBL Data Bank with accession number(s) AF136344 and AF136344.
The amino acid sequence of this protein can be accessed through NCBI Protein Database under NCBI accession numbers 179950, 1078837, and 115709.
To whom correspondence should be addressed: Infectious Diseases
Section, Dept. of Internal Medicine, 808 LCI, 333 Cedar St., New Haven,
CT 06520-8022. Tel.: 203-785-4140; Fax: 203-785-3864; E-mail:
keith.joiner@yale.edu.
2 I. Coppens, A. Sinai, D. Voelker, and K. A. Joiner, unpublished observations.
3 E. Mui, B. Samuel, D. Mack, C. Roberts, C. Pope, F. Roberts, D. Trelease, W. Milhous, D. Kyle, S. Tzipori, and R. McLeod, Fifth Toxoplasma Conference, Marshall, CA, May 1-6, 1999.
| |
ABBREVIATIONS |
|---|
The abbreviations used are: PTS, peroxisomal targeting signal; PBS, phosphate buffered saline; DAB, diaminobenzidine; GST, glutathione S-transferase, T/S, Teorell-Stenhagen buffer; CAT, chloramphenicol acetyltransferase; IFA, immunofluorescence assay; RT-PCR, reverse transcriptase-polymerase chain reaction; CHO, Chinese hamster ovary; PIPES, 1,4-piperazinediethanesulfonic acid; aa, amino acids.
| |
REFERENCES |
|---|
|
|
|---|
| 1. |
Murray, H. W.,
and Cohn, Z. A.
(1979)
J. Exp. Med.
150,
938-949 |
| 2. | Chang, H. R., and Pechere, J. C. (1989) Microb. Pathog. 7, 37-44[CrossRef][Medline] [Order article via Infotrieve] |
| 3. | Sibley, L. D., Lawson, R., and Weidner, E. (1986) Mol. Biochem. Parasitol. 19, 83-87[CrossRef][Medline] [Order article via Infotrieve] |
| 4. |
Gould, S. J.,
Keller, G. A.,
Hosken, N.,
Wilkinson, J.,
and Subramani, S.
(1989)
J. Cell Biol.
108,
1657-1664 |
| 5. |
Purdue, P. E.,
and Lazarow, P. B.
(1996)
J. Cell Biol.
134,
849-862 |
| 6. |
Opperdoes, F. R.,
Baudhuin, P.,
Coppens, I.,
DeRoe, C.,
Edwards, S. W.,
Weijers, P. J.,
and Misset, O.
(1984)
J. Cell Biol.
98,
1178-1184 |
| 7. | Roos, D. S., Donald, R. G., Morissette, N. S., and Moulton, A. L. (1994) Methods Cell Biol. 45, 27-63[Medline] [Order article via Infotrieve] |
| 8. |
Ajioka, J.,
Boothroyd, J. C.,
Brunk, B. P.,
Hehl, A.,
Hillier, L.,
Manger, I. D.,
Overton, G. C.,
Marra, M.,
Roos, D.,
and Sibley, L. D.
(1998)
Genome Res.
8,
18-28 |
| 9. | Frangioni, J. V., and Neel, B. G. (1993) Anal. Biochem. 210, 179-187[CrossRef][Medline] [Order article via Infotrieve] |
| 10. |
Beckers, C. J.,
Dubremetz, J. F.,
Mercereau-Puijalon, O.,
and Joiner, K. A.
(1994)
J. Cell Biol.
127,
947-961 |
| 11. | Karsten, V., Qi, H., Beckers, C. J., and Joiner, K. A. (1997) Methods 13, 103-111[CrossRef][Medline] [Order article via Infotrieve] |
| 12. | Fichera, M. E., and Roos, D. S. (1997) Nature 390, 407-409[CrossRef][Medline] [Order article via Infotrieve] |
| 13. | Deimann, W., Angermüller, S., Stoward, P. J., and Fahimi, H. D. (1991) in Histochemistry (Stoward, P. J. , and Everson Pearse, A. G., eds), Vol. 3 , pp. 573-575, Churchill Livingstone, Edinburgh, UK |
| 14. |
Altschul, S. F.,
Madden, T. L.,
Schäffer, A. A.,
Zhang, J.,
Zhang, Z.,
Miller, W.,
and Lipman, D. J.
(1997)
Nucleic Acids Res.
25,
3389-3402 |
| 15. | von Ossowski, I., Hausner, G., and Loewen, P. C. (1993) J. Mol. Evol. 37, 71-76[Medline] [Order article via Infotrieve] |
| 16. | Gouet, P., Jouve, H.-M., and Dideberg, O. (1995) J. Mol. Biol. 249, 933-954[CrossRef][Medline] [Order article via Infotrieve] |
| 17. | Loewen, P. (1996) Gene (Amst.) 197, 39-44 |
| 18. |
Kirkman, H. N.,
Rolfo, M.,
Ferraris, A. M.,
and Gaetani, G. F.
(1999)
J. Biol. Chem.
274,
13908-13914 |
| 19. | Zamocky, M., Herzog, C., Nykyri, L. M., and Koller, F. (1995) FEBS Lett. 367, 241-245[CrossRef][Medline] [Order article via Infotrieve] |
| 20. | Swinkels, B. W., Gould, S. J., and Subramani, S. (1992) FEBS Lett. 305, 133-136[CrossRef][Medline] [Order article via Infotrieve] |
| 21. |
Waller, R. F.,
Keeling, P. J.,
Donald, R. G. K.,
Striepen, B.,
Handman, E.,
Lang-Unnasch, N.,
Cowman, A. F.,
Gurdyal, S. B.,
Roos, D. S.,
and McFadden, I.
(1998)
Proc. Natl. Acad. Sci. U. S. A.
95,
12352-12357 |
| 22. | Soldati, D. (1999) Parasitol. Today 15, 5-7[CrossRef][Medline] [Order article via Infotrieve] |
| 23. |
Thompson, J. D.,
Higgins, D. G.,
and Gibson, T. J.
(1994)
Nucleic Acids Res.
22,
4673-4680 |
This article has been cited by other articles:
![]() |
A. Schluter, S. Fourcade, R. Ripp, J. L. Mandel, O. Poch, and A. Pujol The Evolutionary Origin of Peroxisomes: An ER-Peroxisome Connection Mol. Biol. Evol., April 1, 2006; 23(4): 838 - 845. [Abstract] [Full Text] [PDF] |
||||
![]() |
X. W. Zhou, B. F. C. Kafsack, R. N. Cole, P. Beckett, R. F. Shen, and V. B. Carruthers The Opportunistic Pathogen Toxoplasma gondii Deploys a Diverse Legion of Invasion and Survival Proteins J. Biol. Chem., October 7, 2005; 280(40): 34233 - 34244. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. E. Akerman and S. Muller Peroxiredoxin-linked Detoxification of Hydroperoxides in Toxoplasma gondii J. Biol. Chem., January 7, 2005; 280(1): 564 - 570. [Abstract] [Full Text] [PDF] |
||||
![]() |
M Ding, C Clayton, and D Soldati Toxoplasma gondii catalase: are there peroxisomes in toxoplasma? J. Cell Sci., January 7, 2000; 113(13): 2409 - 2419. [Abstract] [PDF] |
||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| All ASBMB Journals | Molecular and Cellular Proteomics |
| Journal of Lipid Research | ASBMB Today |